Subscribe
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors

Archive

Genetic test predicts response to weight-loss drugs

Written by | 3 Oct 2025

Mayo Clinic researchers have developed a genetic test that can help predict how people will respond to weight loss medications such as GLP-1s. The test estimates an individual’s… read more.

Inadequate regulatory protections for consumer genetic data privacy in US

Written by | 19 Sep 2025

In a Policy Forum, Natalie Ram and colleagues discuss the concerning gaps in robust regulatory protection on direct-to-consumer genetic data and biospecimens. After declaring bankruptcy in March 2025,… read more.

Genetic testing of IVF embryos helps women over 35 conceive faster

Written by | 3 Sep 2025

Genetic testing of IVF-created embryos could help more women over 35 have a baby in less time, a clinical trial by researchers from King’s College London, King’s College… read more.

Dawnzera (donidalorsen) approved in the U.S. as first and only RNA-targeted prophylactic treatment for hereditary angioedema – Ionis Pharmaceuticals

Written by | 28 Aug 2025

Ionis Pharmaceuticals,Inc. announced that the FDA has approved Dawnzera (donidalorsen) for prophylaxis to prevent attacks of hereditary angioedema (HAE) in adult and pediatric patients 12 years of age… read more.

Autism inpatient collection releases genetic, phenotypic data for more than 1,500 children with autism

Written by | 6 Jul 2025

The Simons Foundation Autism Research Initiative (SFARI) has released phenotypic and genetic data from the Autism Inpatient Collection (AIC), a cohort of more than 1,500 youth participants ages 4 to… read more.

Soleno Therapeutics to present new long-term DCCR fata at largest-ever Prader-Willi Syndrome Conference

Written by | 24 Jun 2025

Soleno Therapeutics, Inc, a biopharmaceutical company developing novel therapeutics for the treatment of rare diseases, today announced one oral and six poster presentations at the 2025 United In… read more.

Advancing personalized medicine through pharmacogenomics: Insights from Ochsner Health

Written by | 23 Jun 2025

In a report recently published in the American Journal of Health-System Pharmacy, the Ochsner Health system delves into the multifaceted implementation of pharmacogenomics—a rapidly evolving field that examines how… read more.

NICE (UK) terminated appraisal for Skyclarys (omaveloxolone) for treating Friedreich’s ataxia in people 16 years and over – Biogen

Written by | 18 Jun 2025

NICE (UK): NICE is unable to make a recommendation on omaveloxolone (Skyclarys) for treating Friedreich’s ataxia in people 16 years and over. This is because Biogen withdrew its… read more.

Smartphone tests could accelerate drug development for Huntington’s disease

Written by | 17 Jun 2025

A series of digital tests, carried out via a smartphone app, could enhance the detection of disease progression in Huntington’s disease and improve the efficiency of clinical trials,… read more.

Largest twin study explores whether the environment affects people differently depending on their genes

Written by | 14 Jun 2025

An international team of researchers led by King’s College London have identified genetic factors that may make some individuals more or less sensitive to the environments they experience…. read more.

Can early exposure to dogs lessen genetic susceptibility to eczema?

Written by | 5 Jun 2025

New research published in Allergy indicates that certain environmental exposures may affect a child’s risk of developing atopic eczema, a condition characterized by dry, itchy, and inflamed skin. In other… read more.

European regulation needed to prevent the birth of children with inherited cancer-causing genetic mutation after sperm donation

Written by | 3 Jun 2025

A case in which a sperm donor was later found to be carrying a cancer-causing pathogenic variant in his gametes has highlighted the problems of regulating gamete donation… read more.

Newsletter Icon

Subscribe for our mailing list

If you're a healthcare professional you can sign up to our mailing list to receive high quality medical, pharmaceutical and healthcare E-Mails and E-Journals. Get the latest news and information across a broad range of specialities delivered straight to your inbox.

Subscribe

You can unsubscribe at any time using the 'Unsubscribe' link at the bottom of all our E-Mails, E-Journals and publications.